Together these data demonstrate that 15-PGDH is abundantly expressed and highly enzymatically active in the murine lung and provide rationale for pharmacologic targeting of 15-PGDH as a strategy to increase local PGE2 and limit the pathogenesis of pulmonary fibrosis (PF). This evidence concerns the gene HPGD and pulmonary fibrosis.